Table 3 Comparison of patient backgrounds between the beta 2 microglobulin increase group and the decrease group
Increased group (n = 2) | Decreased group (n = 9) | P value | |
|---|---|---|---|
Age | 50.0 ± 4 | 57.8 ± 13.8 | 0.436 |
Body mass index | 23.1 ± 0.9 | 25.9 ± 4.6 | 0.582 |
Vintage of PD therapy | 2.5 ± 1.9 | 3.6 ± 1.0 | 0.582 |
Hemoglobin | 10.9 ± 0.4 | 11.2 ± 1.3 | 1.000 |
Serum albumin | 3.1 ± 0.1 | 3.3 ± 0.3 | 0.436 |
Blood urea nitrogen | 73.8 ± 19.3 | 47.6 ± 13.4 | 0.145 |
Creatinine | 13.4 ± 2.5 | 14.0 ± 4.4 | 1.000 |
C-reactive protein | 0.1 ± 0.1 | 0.4 ± 0.7 | 0.909 |
Baseline beta 2 microglobulin | 32.9 ± 0.4 | 37.5 ± 7.2 | 1.000 |
Total PD fluid volume | 8.7 ± 0.8 | 9.8 ± 2.2 | 0.582 |
Weekly Kt/V of PD | 1.5 ± 0 | 1.7 ± 0.3 | 0.727 |
Blood flow rate of HD session | 235 ± 15 | 250 ± 27.5 | 0.582 |
Kt/V of HD | 1.4 ± 0.3 | 1.5 ± 0.3 | 1.000 |
Renal Kt/V | 0.01 ± 0.01 | 0 | 0.327 |
Urine volume | 200 ± 200 | 0 | 0.327 |
Renal CCr | 4.0 ± 4.0 | 0 | 0.327 |